Use of antiretroviral therapy in pregnancy and association with birth outcome among women living with HIV in Denmark: A nationwide, population-based cohort study.
Moseholm EllenTerese Lea KatzensteinGitte PedersenIsik Somuncu JohansenLisa Skyggelund WieneckeMerete StorgaardNiels ObelNina WeisPublished in: HIV medicine (2022)
Pregnant WLWH living in Denmark are generally well treated with HIV RNA < 50 copies/mL at delivery and NRTI + PI as the most common ART regimen used in pregnancy. Initiation of ART in the first trimester may be associated with poor fetal growth. The association between ART use in pregnancy and adverse birth outcomes may partly be explained by maternal risk factors.
Keyphrases
- antiretroviral therapy
- pregnancy outcomes
- hiv infected
- pregnant women
- hiv positive
- human immunodeficiency virus
- hiv aids
- hiv infected patients
- risk factors
- preterm birth
- gestational age
- birth weight
- polycystic ovary syndrome
- emergency department
- hepatitis c virus
- metabolic syndrome
- skeletal muscle
- adverse drug
- south africa
- nucleic acid
- weight gain
- breast cancer risk
- body mass index